Coronary CT Angiogram - Prognostic Value of Adverse Plaque Features in Guiding Treatment (CT-PLAQUE)

The University of Hong Kong (HKU)

Status: Active, not recruiting

Conditions: Determining if the Presence of Adverse Plaque Features Identified From the CT Angiogram Can Help Determining Prognosis and Guide Treatment Options

Treatments: Diagnostic Test: CTCA

Study type: Observational

Funder types: Other

Identifiers

NCT07212751

UW20-057

Details and patient eligibility

About

The study aims at determining if the presence of adverse plaque features identified from the CT angiogram can help determine prognosis and guide treatment options.

Enrollment: 22,000 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who is ≥ 18 years old presented with chest pain and has undergone CTA between 01-Jan-2012 and 31-Dec-2022 before treatment
• If multiple CTAs are taken, the most updated one before treatment commencement will be chosen.

Exclusion criteria

• Patient who did not undergo cardiac CT scan due to inability to undergo cardiac CT scanning, kidney failure (serum creatinine >250 μmol/L or estimated glomerular filtration rate <30 mL/min), major allergy to contrast.

Trial design

22,000 participants in 1 patient group

Patient who is ≥ 18 years old presented with chest pain and has undergone CTA before treatment

Treatment:

Diagnostic Test: CTCA